A potential role for zinc in restless legs syndrome
- PMID: 33175142
- PMCID: PMC8033460
- DOI: 10.1093/sleep/zsaa236
A potential role for zinc in restless legs syndrome
Abstract
Study objectives: Evaluate serum and brain noniron metals in the pathology and genetics of restless legs syndrome (RLS).
Methods: In two independent studies (cohorts 1 and 2), in which subjects either remained on medications or tapered off medications, we analyzed serum levels of iron, calcium, magnesium, manganese, copper, and zinc both in RLS patients and controls, and assessed the prevalence of the MEIS1 and BTBD9 risk alleles previously established through genome-wide association studies. Human brain sections and a nematode genetic model were also quantified for metal levels using mass spectrometry.
Results: We found a significant enrichment for the BTBD9 risk genotype in the RLS affected group compared to control (p = 0.0252), consistent with previous literature. Serum (p = 0.0458 and p = 0.0139 for study cohorts 1 and 2, respectively) and brain (p = 0.0413) zinc levels were significantly elevated in the RLS patients versus control subjects.
Conclusion: We show for the first time that serum and brain levels of zinc are elevated in RLS. Further, we confirm the BTBD9 genetic risk factor in a new population, although the zinc changes were not significantly associated with risk genotypes. Zinc and iron homeostasis are interrelated, and zinc biology impacts neurotransmitter systems previously linked to RLS. Given the modest albeit statistically significant increase in serum zinc of ~20%, and the lack of association with two known genetic risk factors, zinc may not represent a primary etiology for the syndrome. Further investigation into the pathogenetic role that zinc may play in restless legs syndrome is needed.
Keywords: essential metals; restless legs syndrome; zinc.
© Sleep Research Society 2020. Published by Oxford University Press on behalf of the Sleep Research Society. All rights reserved. For permissions, please e-mail journals.permissions@oup.com.
Figures
![Figure 1.](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/8033460/bin/zsaa236_fig1.gif)
![Figure 2.](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/8033460/bin/zsaa236_fig2.gif)
![Figure 3.](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/8033460/bin/zsaa236_fig3.gif)
![Figure 4.](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/8033460/bin/zsaa236_fig4.gif)
![Figure 5.](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/8033460/bin/zsaa236_fig5.gif)
Comment in
-
The conundrum of the origin of restless legs syndrome.Sleep. 2022 May 12;45(5):zsac018. doi: 10.1093/sleep/zsac018. Epub 2022 Feb 2. Sleep. 2022. PMID: 35554576 No abstract available.
Similar articles
-
Association of BTBD9 and MAP2K5/SKOR1 With Restless Legs Syndrome in Chinese Population.Sleep. 2017 Apr 1;40(4). doi: 10.1093/sleep/zsx028. Sleep. 2017. PMID: 28329290
-
Susceptible genes of restless legs syndrome in migraine.Cephalalgia. 2016 Oct;36(11):1028-1037. doi: 10.1177/0333102415620907. Epub 2016 Jul 19. Cephalalgia. 2016. PMID: 26643377
-
MEIS1 and BTBD9: genetic association with restless leg syndrome in end stage renal disease.J Med Genet. 2011 Jul;48(7):462-6. doi: 10.1136/jmg.2010.087858. Epub 2011 May 14. J Med Genet. 2011. PMID: 21572129 Free PMC article.
-
Role of MEIS1 in restless legs syndrome: From GWAS to functional studies in mice.Adv Pharmacol. 2019;84:175-184. doi: 10.1016/bs.apha.2019.03.003. Epub 2019 Apr 9. Adv Pharmacol. 2019. PMID: 31229170 Review.
-
Genetics of restless legs syndrome.Curr Neurol Neurosci Rep. 2008 May;8(3):211-6. doi: 10.1007/s11910-008-0033-y. Curr Neurol Neurosci Rep. 2008. PMID: 18541116 Review.
Cited by
-
Correlates of Restless Legs Syndrome in Older People.J Clin Med. 2024 Feb 28;13(5):1364. doi: 10.3390/jcm13051364. J Clin Med. 2024. PMID: 38592261 Free PMC article.
-
Review of the role of the endogenous opioid and melanocortin systems in the restless legs syndrome.Brain. 2024 Jan 4;147(1):26-38. doi: 10.1093/brain/awad283. Brain. 2024. PMID: 37633259 Free PMC article.
-
Serum Trace Elements Concentrations in Patients with Restless Legs Syndrome.Antioxidants (Basel). 2022 Jan 29;11(2):272. doi: 10.3390/antiox11020272. Antioxidants (Basel). 2022. PMID: 35204155 Free PMC article.
-
BTBD9 attenuates manganese-induced oxidative stress and neurotoxicity by regulating insulin growth factor signaling pathway.Hum Mol Genet. 2022 Jul 7;31(13):2207-2222. doi: 10.1093/hmg/ddac025. Hum Mol Genet. 2022. PMID: 35134179 Free PMC article.
References
-
- Allen RP, et al. ; International Restless Legs Syndrome Study Group (IRLSSG). Evidence-based and consensus clinical practice guidelines for the iron treatment of restless legs syndrome/Willis-Ekbom disease in adults and children: an IRLSSG task force report. Sleep Med. 2018;41:27–44. - PubMed
-
- Allen RP, et al. MRI measurement of brain iron in patients with restless legs syndrome. Neurology. 2001;56(2):263–265. - PubMed
-
- Earley CJ, et al. Abnormalities in CSF concentrations of ferritin and transferrin in restless legs syndrome. Neurology. 2000;54(8):1698–1700. - PubMed
-
- Connor JR, et al. Neuropathological examination suggests impaired brain iron acquisition in restless legs syndrome. Neurology. 2003;61(3):304–309. - PubMed
-
- O’Keeffe ST, et al. Iron status and restless legs syndrome in the elderly. Age Ageing. 1994;23(3):200–203. - PubMed